Troubles continue for voice recognition technology provider Lernout & Hauspie (HNN 10/18/00). With the U.S. Securities and Exchange Commission and the Easdaq stock exchange both investigating accusations of questionable accounting practices
Troubles continue for voice recognition technology provider Lernout & Hauspie (HNN 10/18/00). With the U.S. Securities and Exchange Commission and the Easdaq stock exchange both investigating accusations of questionable accounting practices by L&H, Easdaq and Nasdaq have halted trading of the company's shares. Trading will not resume on either exchange until the firm has fully satisfied Nasdaq's request for additional information.
L&H, which is also facing a number of class action lawsuits, is in the process of restating its financial results from the past two and a half years. The beleaguered VR vendor is considering measures including staffing cuts and pulling back product lines to speed its return to profitability.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 5.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
2 Commerce Drive
Cranbury, NJ 08512